Medications
Supreme Court takes up drug company dispute
The Supreme Court is wading into a patent dispute between rival pharmaceutical companies over a multiple sclerosis treatment.
Mar 31, 2014
0
0
News tagged with generic company
Medications
US: 'Pay to delay' generic drugs can be illegal (Update)
The Supreme Court ruled Monday that deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can be sometimes be illegal and ...
Jun 17, 2013
0
0
Health
Medicare beneficiaries substantially more likely to use brand-name drugs than VA patients
Medicare beneficiaries with diabetes are two to three times more likely to use expensive brand-name drugs than a comparable group of patients treated within the VA Healthcare System, according to a nationwide study by researchers ...
Jun 10, 2013
0
0
Medications
Drug companies' patent-extending strategies substantially increase health care costs
Evergreening strategies—where pharmaceutical companies slightly change the formulation of their brand drug into "follow on" drugs by combining formulations or producing slow-release forms, for example, so that they can ...
Jun 4, 2013
0
0
Medications
Drug manufacturer agrees to $500 million penalty (Update)
A subsidiary of India's largest pharmaceutical company has agreed to pay a record $500 million in fines and penalties for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown ...
May 13, 2013
0
0
Other
Sanofi earnings slashed in first quarter
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
May 2, 2013
0
0
Medications
Lundbeck profit jumps but warns on generic pressure
Danish pharmaceutical company Lundbeck Wednesday posted a higher than expected quarterly net profit, helped by the expansion of an alliance with Japan's Otsuka and the divestment of a US portfolio of non-core products.
May 1, 2013
0
0
Medications
Misuse of drug patenting could cost the health system billions
(Medical Xpress)—Companies may be misusing the drug patenting system in order to gain control over high-cost drugs in Australia, research from the Melbourne Law School has found.
Apr 10, 2013
0
0
Medications
India's rejection of drug patent could reverberate
The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world's largest drugmakers.
Apr 1, 2013
0
0
Medications
High court weighs drug companies' generics policy
(AP)—The Supreme Court is struggling with whether it should stop pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs.
Mar 25, 2013
0
0
